Skip to main content
Clinical Trials/NCT03304925
NCT03304925
Unknown
Not Applicable

CoolSculpting the Flanks

Zeltiq Aesthetics7 sites in 1 country320 target enrollmentOctober 25, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Fat Disorder
Sponsor
Zeltiq Aesthetics
Enrollment
320
Locations
7
Primary Endpoint
Effectiveness endpoint gauged by reduction in fat layer thickness
Last Updated
5 years ago

Overview

Brief Summary

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flanks.

Registry
clinicaltrials.gov
Start Date
October 25, 2017
End Date
August 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zeltiq Aesthetics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effectiveness endpoint gauged by reduction in fat layer thickness

Time Frame: Final post-treatment visit

Reduction in fat layer thickness as measured by ultrasound at the final post-treatment visit.

Safety endpoint in relation to adverse events

Time Frame: Final post treatment visit

Measurement of device- or procedure-related adverse events. It is expected there will be zero UADEs

Secondary Outcomes

  • Subject survey(Final post-treatment visit)
  • Photo review(Final post-treatment visit)

Study Sites (7)

Loading locations...

Similar Trials